The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The global Nocturia market was valued at US$ 2136.6 million in 2023 and is anticipated to reach US$ 3423.5 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
Report Scope
The Nocturia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by Type, by Sale Channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channels, and by regions.
Market Segmentation
By Company
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The global Nocturia market was valued at US$ 2136.6 million in 2023 and is anticipated to reach US$ 3423.5 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
Report Scope
The Nocturia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by Type, by Sale Channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channels, and by regions.
Market Segmentation
By Company
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Sale Channels
1.3.1 Global Nocturia Market Growth by Sale Channels: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2019-2030)
2.2 Nocturia Growth Trends by Region
2.2.1 Global Nocturia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nocturia Historic Market Size by Region (2019-2024)
2.2.3 Nocturia Forecasted Market Size by Region (2025-2030)
2.3 Nocturia Market Dynamics
2.3.1 Nocturia Industry Trends
2.3.2 Nocturia Market Drivers
2.3.3 Nocturia Market Challenges
2.3.4 Nocturia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Revenue
3.1.1 Global Top Nocturia Players by Revenue (2019-2024)
3.1.2 Global Nocturia Revenue Market Share by Players (2019-2024)
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nocturia Revenue
3.4 Global Nocturia Market Concentration Ratio
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2023
3.5 Nocturia Key Players Head office and Area Served
3.6 Key Players Nocturia Product Solution and Service
3.7 Date of Enter into Nocturia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturia Breakdown Data by Type
4.1 Global Nocturia Historic Market Size by Type (2019-2024)
4.2 Global Nocturia Forecasted Market Size by Type (2025-2030)
5 Nocturia Breakdown Data by Sale Channels
5.1 Global Nocturia Historic Market Size by Sale Channels (2019-2024)
5.2 Global Nocturia Forecasted Market Size by Sale Channels (2025-2030)
6 North America
6.1 North America Nocturia Market Size (2019-2030)
6.2 North America Nocturia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nocturia Market Size by Country (2019-2024)
6.4 North America Nocturia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nocturia Market Size (2019-2030)
7.2 Europe Nocturia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nocturia Market Size by Country (2019-2024)
7.4 Europe Nocturia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nocturia Market Size (2019-2030)
8.2 Asia-Pacific Nocturia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nocturia Market Size by Region (2019-2024)
8.4 Asia-Pacific Nocturia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nocturia Market Size (2019-2030)
9.2 Latin America Nocturia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nocturia Market Size by Country (2019-2024)
9.4 Latin America Nocturia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturia Market Size (2019-2030)
10.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nocturia Market Size by Country (2019-2024)
10.4 Middle East & Africa Nocturia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2019-2024)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Detail
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2019-2024)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2019-2024)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2019-2024)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2019-2024)
11.10.5 Mylan Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Nocturia Introduction
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2019-2024)
11.11.5 Johnson & Johnson Recent Development
11.12 Hainan Zhonghe Pharmaceutical
11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2019-2024)
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Desmopressin
Table 3. Key Players of Anticholinergic Drugs
Table 4. Key Players of Alpha Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Nocturia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Nocturia Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Nocturia Market Share by Region (2019-2024)
Table 11. Global Nocturia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Nocturia Market Share by Region (2025-2030)
Table 13. Nocturia Market Trends
Table 14. Nocturia Market Drivers
Table 15. Nocturia Market Challenges
Table 16. Nocturia Market Restraints
Table 17. Global Nocturia Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Nocturia Market Share by Players (2019-2024)
Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2023)
Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nocturia Product Solution and Service
Table 24. Date of Enter into Nocturia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nocturia Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Nocturia Revenue Market Share by Type (2019-2024)
Table 28. Global Nocturia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Nocturia Revenue Market Share by Type (2025-2030)
Table 30. Global Nocturia Market Size by Sale Channels (2019-2024) & (US$ Million)
Table 31. Global Nocturia Revenue Market Share by Sale Channels (2019-2024)
Table 32. Global Nocturia Forecasted Market Size by Sale Channels (2025-2030) & (US$ Million)
Table 33. Global Nocturia Revenue Market Share by Sale Channels (2025-2030)
Table 34. North America Nocturia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Nocturia Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Nocturia Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Nocturia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Nocturia Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Nocturia Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Nocturia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Nocturia Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Nocturia Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Nocturia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Nocturia Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Nocturia Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Nocturia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Nocturia Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Nocturia Market Size by Country (2025-2030) & (US$ Million)
Table 49. Astellas Pharma Company Detail
Table 50. Astellas Pharma Business Overview
Table 51. Astellas Pharma Nocturia Product
Table 52. Astellas Pharma Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 53. Astellas Pharma Recent Development
Table 54. Allergan Company Detail
Table 55. Allergan Business Overview
Table 56. Allergan Nocturia Product
Table 57. Allergan Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Ferring Pharmaceuticals Company Detail
Table 60. Ferring Pharmaceuticals Business Overview
Table 61. Ferring Pharmaceuticals Nocturia Product
Table 62. Ferring Pharmaceuticals Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 63. Ferring Pharmaceuticals Recent Development
Table 64. Eli Lilly Company Detail
Table 65. Eli Lilly Business Overview
Table 66. Eli Lilly Nocturia Product
Table 67. Eli Lilly Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 68. Eli Lilly Recent Development
Table 69. GlaxoSmithKline Company Detail
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Nocturia Product
Table 72. GlaxoSmithKline Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Nocturia Product
Table 77. Sanofi Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Pfizer Company Detail
Table 80. Pfizer Business Overview
Table 81. Pfizer Nocturia Product
Table 82. Pfizer Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Abbott Company Detail
Table 85. Abbott Business Overview
Table 86. Abbott Nocturia Product
Table 87. Abbott Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Teva Company Detail
Table 90. Teva Business Overview
Table 91. Teva Nocturia Product
Table 92. Teva Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 93. Teva Recent Development
Table 94. Mylan Company Detail
Table 95. Mylan Business Overview
Table 96. Mylan Nocturia Product
Table 97. Mylan Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 98. Mylan Recent Development
Table 99. Johnson & Johnson Company Detail
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Nocturia Product
Table 102. Johnson & Johnson Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 103. Johnson & Johnson Recent Development
Table 104. Hainan Zhonghe Pharmaceutical Company Detail
Table 105. Hainan Zhonghe Pharmaceutical Business Overview
Table 106. Hainan Zhonghe Pharmaceutical Nocturia Product
Table 107. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2019-2024) & (US$ Million)
Table 108. Hainan Zhonghe Pharmaceutical Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nocturia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nocturia Market Share by Type: 2023 VS 2030
Figure 3. Desmopressin Features
Figure 4. Anticholinergic Drugs Features
Figure 5. Alpha Blockers Features
Figure 6. Diuretics Features
Figure 7. Others Features
Figure 8. Global Nocturia Market Size Comparison by Sale Channels (2024-2030) & (US$ Million)
Figure 9. Global Nocturia Market Share by Sale Channels: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Nocturia Report Years Considered
Figure 14. Global Nocturia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Nocturia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Nocturia Market Share by Region: 2023 VS 2030
Figure 17. Global Nocturia Market Share by Players in 2023
Figure 18. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2023
Figure 20. North America Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Nocturia Market Share by Country (2019-2030)
Figure 22. United States Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Nocturia Market Share by Country (2019-2030)
Figure 26. Germany Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Nocturia Market Share by Region (2019-2030)
Figure 34. China Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Nocturia Market Share by Country (2019-2030)
Figure 42. Mexico Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Nocturia Market Share by Country (2019-2030)
Figure 46. Turkey Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Nocturia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Astellas Pharma Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 49. Allergan Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 50. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 51. Eli Lilly Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 55. Abbott Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 56. Teva Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 57. Mylan Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 58. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 59. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
